We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+18.09%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
–
Cap. Flow
+$142M
Cap. Flow %
94.05%
Top 10 Hldgs %
64.81%
Holding
17
New
17
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CHRS icon
Coherus Oncology
CHRS
+$10.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$10M
3
COLL icon
Collegium Pharmaceutical
COLL
+$9.37M
4
COR icon
Cencora
COR
+$9.3M
5
CI icon
Cigna
CI
+$9.22M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
1
Supernus Pharmaceuticals
SUPN
$2.74B
$11.7M 7.75%
+465,000
New +$10M
CHRS icon
2
Coherus Oncology
CHRS
$191M
$10.4M 6.91%
+600,000
New +$10.7M
VTRS icon
3
Viatris
VTRS
$19.6B
$9.84M 6.52%
+525,000
New +$8.56M
CI icon
4
Cigna
CI
$72.8B
$9.78M 6.48%
+47,000
New +$9.22M
COLL icon
5
Collegium Pharmaceutical
COLL
$947M
$9.61M 6.37%
+480,000
New +$9.37M
IRWD icon
6
Ironwood Pharmaceuticals
IRWD
$700M
$9.51M 6.3%
+835,000
New +$9.14M
UHS icon
7
Universal Health Services
UHS
$10.2B
$9.35M 6.19%
+68,000
New +$8.46M
ABBV icon
8
AbbVie
ABBV
$432B
$9.32M 6.17%
+87,000
New +$8.36M
MCK icon
9
McKesson
MCK
$102B
$9.22M 6.1%
+53,000
New +$8.83M
COR icon
10
Cencora
COR
$62.6B
$9.09M 6.02%
+93,000
New +$9.3M
BMY icon
11
Bristol-Myers Squibb
BMY
$131B
$9.06M 6%
+146,000
New +$8.98M
CAH icon
12
Cardinal Health
CAH
$55.9B
$9.05M 5.99%
+169,000
New +$8.77M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$40.3B
$8.83M 5.85%
+915,000
New +$8.77M
ARAY icon
14
Accuray
ARAY
$34.1M
$6.88M 4.56%
+1,650,000
New +$6.05M
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
$6.86M 4.55%
+1,720,000
New +$5.56M
BDSI
16
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$6.62M 4.38%
+1,575,000
New +$6.07M
CPRX
17
DELISTED
Catalyst Pharmaceutical
CPRX
$5.84M 3.87%
+1,750,000
New +$5.88M

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
PC
Prevatt Capital Nassau, Bahamas $371M AUM 9.39% 1-Year Est. Return

HealthInvest Partners's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for HealthInvest Partners, which disclosed 17 positions worth $151M. Its ten largest holdings account for 65% of the portfolio.

Its largest position is Coherus Oncology: 600,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • HealthInvest Partners's largest Q4 2020 buy was Coherus Oncology: 600,000 shares worth $10.4M.
  • HealthInvest Partners's ten largest holdings make up 65% of its $151M portfolio in Q4 2020.
  • HealthInvest Partners disclosed 17 positions in Q4 2020, its first 13F filing on record.

Based on HealthInvest Partners's 13F filing for Q4 2020, filed 5 Feb 2021.